Skip to main navigation Skip to search Skip to main content

Association of CCR5 Δ32 with reduced risk of asthma

  • Ian P. Hall*
  • , Amanda Wheatley
  • , Gordon Christie
  • , Catherine McDougall
  • , Richard Hubbard
  • , Peter J. Helms
  • *Corresponding author for this work

Research output: Journal PublicationArticlepeer-review

Abstract

We report that individuals carrying the CCR5Δ32 mutation, a naturally occurring variant of the C-C chemokine receptor 5 (CCR5), are at reduced risk of developing asthma. These data suggest a possible explanation for the high prevalence of this mutation in the general population.

Original languageEnglish
Pages (from-to)1264-1265
Number of pages2
JournalThe Lancet
Volume354
Issue number9186
DOIs
Publication statusPublished - 9 Oct 1999
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Association of CCR5 Δ32 with reduced risk of asthma'. Together they form a unique fingerprint.

Cite this